A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare insulin peglispro (LY2605541) to insulin glargine in
Asian insulin naïve participants who have been treated with oral anti hyperglycemia
medications. Participants will receive 26 weeks of treatment.